All entries for: Regeneron Pharmaceuticals Inc.

July 14, 2026

Regeneron Pharmaceuticals Inc.

Orphan Drug Designation

treatment of Netherton syndrome

Disease Area: Rare Diseases
November 10, 2025

Regeneron Pharmaceuticals Inc.

Orphan Drug Designation

FDA orphan drug designation: treatment of pulmonary arterial hypertension

Disease Area: Rare Diseases
Scroll to Top